Printer Friendly

COMPANY INFORMATION
biOasis Technologies Inc. 3489 Canterbury Pl South Surrey, BC V3S 0G8 Tel: (604) 542-5059 Fax: (604) 542-5069 Contact Name Robin B. Hutchison Industry Pharmaceuticals		Key Executives Robin B. Hutchison, CEO David Clark, CFO Developing a diagnostic test for Alzheimer's disease.
FP ADVISOR COVERAGE biOasis Technologies Inc. • FP Corporate Surveys • FP Directory of Directors • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/BTI $0.70 $0.97 $0.34 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 36,262 n.a. $-0.07 Nov. 30/09 70.73% n.a. n.a. $19,455
ANNUAL FINANCIALS Periods ended: 12m Feb. 28/09 12m Feb. 29/081 $000s $000s Net income (1,150) (131) Total assets 2,093 631 $ $ Earnings per share* (0.07) (0.04) % % Return on equity (86.92) n.m.   * Common 1 Results pertain to old biOasis Technologies Inc. (predcessor private company)

COMPANY NEWS

Results for 'biOasis Technologies Inc.' from past 30 days: No hits. (Links are to articles.)